School of Health and Biomedical Sciences, RMIT University, PO Box 71, Bundoora West Campus, Victoria 3083, Australia.
School of Science, RMIT University, GPO Box 2476, Melbourne, Victoria 3001, Australia.
Int J Mol Sci. 2020 Apr 19;21(8):2854. doi: 10.3390/ijms21082854.
Obesity is a multifactorial disease that can lead to other health issues. Glucagon-like peptide-1(GLP-1), as one of the satiety signal, has been linked with appetite suppression and weight loss. Due to the limitations of GLP-1 and its analogues, alternative treatments such as herbal therapies have become popular. The herbal formula RCM-107 has demonstrated its inhibitory effects on lipid and carbohydrate absorption in our previous work. However, no published data described its effects on GLP-1 secretion. Therefore, this study aimed to determine the effects of RCM-107 and its individual ingredients on GLP-1 secretion via enzyme-linked immunosorbent assay (ELISA). Furthermore, molecular docking was performed to predict the key chemical compounds that are likely to be GLP-1 receptor agonists. , one of the ingredients in RCM-107, demonstrated significantly greater effects on inducing GLP-1 secretion than the positive control epigallocatechin gallate (EGCG). Two ligands, 3-epioleanolic acid and crocin were predicted to bind to the active form of GLP-1 receptor at the binding pocket with residues known for the receptor activation, suggesting that they could potentially serve as receptor agonists. Overall, this study reported the effects of researched herbs on GLP-1 secretion and proposed two compounds that may be responsible for antiobesity via GLP-1 receptor activation.
肥胖是一种多因素疾病,可导致其他健康问题。胰高血糖素样肽-1(GLP-1)作为一种饱腹感信号,与食欲抑制和体重减轻有关。由于 GLP-1 及其类似物的局限性,替代治疗方法,如草药疗法,已变得流行。在我们之前的工作中,草药配方 RCM-107 已证明其对脂质和碳水化合物吸收的抑制作用。然而,没有发表的数据描述其对 GLP-1 分泌的影响。因此,本研究旨在通过酶联免疫吸附试验(ELISA)确定 RCM-107 及其各成分对 GLP-1 分泌的影响。此外,还进行了分子对接,以预测可能作为 GLP-1 受体激动剂的关键化学化合物。在 RCM-107 的一种成分中,3-表橄榄酸显示出比阳性对照表没食子儿茶素没食子酸酯(EGCG)更大的诱导 GLP-1 分泌的作用。两种配体,3-表齐墩果酸和西红花酸被预测与已知的受体激活的 GLP-1 受体的活性形式结合在结合口袋中,表明它们可能潜在地作为受体激动剂。总的来说,本研究报告了研究草药对 GLP-1 分泌的影响,并提出了两种可能通过 GLP-1 受体激活来发挥抗肥胖作用的化合物。